心不全部
研究業績
  1. Miyoshi Y, Kaji S, Masumoto A, Kim K, Kitai T, Kinoshita M, Furukawa Y. Aortic enlargement in two weeks is associated with subsequent aortic events in patients with type B acute aortic syndrome. The Journal of Thoracic and Cardiovascular Surgery. 166, 410-418.e1, 2023.
  2. Dimos A, Xanthopoulos A, Giamouzis G, Kitai T, Economou D, Skoularigis J, Triposkiadis F. The "vulnerable" post hospital discharge period in acutely decompensated chronic vs. De-Novo heart failure: Outcome prediction using the Larissa Heart Failure Risk Score. Hellenic Journal of Cardiology. 71, 58-60, 2023.
  3. Aida K, Nagao K, Kato T, Yaku H, Morimoto T, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Su K, Kawato M, Seko Y, Inada T, Inoko M, Toyofuku M, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Shizuta S, Ono K, Sato Y, Kuwahara K, Ozasa N, Kimura T. Prognostic Value of the Severity of Clinical Congestion in Patients Hospitalized for Decompensated Heart Failure: Findings From the Japanese KCHF Registry. Journal of Cardiac Failure. 29, 1150-1162, 2023.
  4. Takahama H, Nishimura K, Ahsan B, Hamatani Y, Makino Y, Nakagawa S, Irie Y, Moriuchi K, Amano M, Okada A, Kitai T, Amaki M, Kanzaki H, Noguchi T, Kusano K, Akao M, Yasuda S, Izumi C. Clinical application of artificial intelligence algorithm for prediction of one-year mortality in heart failure patients. Heart and Vessels. 38, 785-792, 2023.
  5. Abe T, Jujo K, Maeda D, Saito K, Ogasahara Y, Saito K, Saito H, Iwata K, Konishi M, Kitai T, Kasai T, Wada H, Momomura SI, Kagiyama N, Kamiya K, Yamashita M, Hamazaki N, Nozaki K, Maekawa E, Ako J, Matsue Y. The interaction between physical frailty and prognostic impact of heart failure medication in elderly patients. ESC Heart Failure. 10, 1698-1705, 2023.
  6. Kitai T, Kim K. Optimal stress testing for dynamic functional mitral regurgitation in patients with acute decompensated heart failure. European Heart Journal - Case Reports. 7, ytad121, 2023.
  7. Shiba M, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Seko Y, Yamamoto E, Yoshikawa Y, Kitai T, Yamashita Y, Iguchi M, Nagao K, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T. Heterogeneity in Characteristics and Outcomes of Patients who met the Indications for Vericiguat Approved by the Japanese Agency: From the KCHF Registry. Journal of Cardiac Failure. 29, 976-978, 2023.
  8. Hamatani Y, Iguchi M, Moriuchi K, Anchi Y, Inuzuka Y, Nishikawa R, Shimamura K, Kondo H, Mima H, Yamashita Y, Takabayashi K, Takenaka K, Korai K, Kawase Y, Murai R, Yaku H, Nagao K, Kitano M, Aono Y, Kitai T, Sato Y, Kimura T, Akao M. Effectiveness and safety of morphine administration for refractory dyspnoea among hospitalised patients with advanced heart failure: the Morphine-HF study. BMJ Supportive & Palliative Care. 13, e1300-e1307, 2023.
  9. Tanaka H, Takegami M, Miyake M, Amano M, Kitai T, Fujita T, Koyama T, Ando K, Komiya T, Izumo M, Kawai H, Eishi K, Yoshida K, Kimura T, Nawada R, Sakamoto T, Shibata Y, Fukui T, Minatoya K, Tsujita K, Sakata Y, Kimura T, Nishimura K, Furukawa Y, Izumi C; BPV-AF Registry Group. Association of Left Atrial Size With Stroke or Systemic Embolism in Patients With Atrial Fibrillation Having Undergone Bioprosthetic Valve Replacement From the BPV-AF Registry. Circulation Reports. 5, 210-216, 2023.
  10. Masumoto A, Azumi Y, Kaji S, Miyoshi Y, Kim K, Kitai T, Furukawa Y. Impact of antithrombotic therapy on clinical outcomes in patients with type B acute aortic syndrome. JTCVS Open. 14, 36-45, 2023.
  11. Maekawa E, Noda T, Maeda D, Yamashita M, Uchida S, Hamazaki N, Nozaki K, Saito H, Saito K, Ogasahara Y, Konishi M, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Nagamatsu H, Ozawa T, Izawa K, Yamamoto S, Aizawa N, Yonezawa R, Oka K, Ako J, Momomura SI, Kagiyama N, Matsue Y, Kamiya K. Prognostic impact of cachexia by multi-assessment in older adults with heart failure: FRAGILE-HF cohort study. Journal of Cachexia, Sarcopenia and Muscle. 14, 2143-2151, 2023.
  12. Donal E, Tribouilloy C, Sadeghpour A, Laroche C, Tude Rodrigues AC, Pereira Nunes MDC, Kang DH, Hernadez-Meneses M, Kobalava Z, De Bonis M, Dworakowski R, Ivanovic B, Holicka M, Kitai T, Cruz I, Huttin O, Colonna P, Lancellotti P, Habib G. Cardiac device-related infective endocarditis need for lead extraction whatever the device according to the ESC EORP EURO-ENDO registry. European Heart Journal Open. 3, oead064, 2023.
  13. Takeji Y, Taniguchi T, Morimoto T, Shirai S, Kitai T, Tabata H, Kitano K, Ono N, Murai R, Osakada K, Murata K, Nakai M, Tsuneyoshi H, Tada T, Amano M, Shiomi H, Watanabe H, Yoshikawa Y, Yamamoto K, Toyofuku M, Tatsushima S, Kanamori N, Miyake M, Nakayama H, Nagao K, Izuhara M, Nakatsuma K, Inoko M, Fujita T, Kimura M, Ishii M, Usami S, Sawada K, Nakazeki F, Okabayashi M, Shirotani M, Inuzuka Y, Komiya T, Minatoya K, Kimura T; CURRENT AS Registry-2 Investigators. CORRIGENDUM: Rationale, Design, and Baseline Characteristics of the CURRENT AS Registry-2. Circulation Journal. 87, 1146-1149, 2023.
  14. Okabe T, Nabeta T, Naruse Y, Taniguchi T, Kitai T, Yoshioka K, Tanaka H, Okumura T, Baba Y, Matsue Y. Prognostic Implication of the Resolution of Myocardial FDG Uptake in Patients With Cardiac Sarcoidosis. JACC: Asia. 3, 683-685, 2023.
  15. Nishikawa R, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Ozasa N, Tada T, Sakamoto H, Seko Y, Shiba M, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. The characteristics and outcomes in patients with acute heart failure who used tolvaptan: from KCHF registry. ESC Heart Failure. 10, 3141-3151, 2023.
  16. Suzuki S, Kitai T, Skoularigis J, Spiliopoulos K, Xanthopoulos A. Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: Current Evidence and Future Opportunities. Journal of Personalized Medicine. 13, 1394, 2023.
  17. Kurashima S, Kitai T, Xanthopoulos A, Skoularigis J, Triposkiadis F, Izumi C. Diagnosis of cardiac sarcoidosis: histological evidence vs. imaging. Expert Review of Cardiovascular Therapy. 21, 693-702, 2023.
  18. Fujimoto Y, Matsue Y, Maeda D, Dotare T, Sunayama T, Iso T, Nakamura Y, Singh YS, Akama Y, Yoshioka K, Kitai T, Naruse Y, Taniguchi T, Tanaka H, Okumura T, Baba Y, Nabeta T, Minamino T. Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis. European Heart Journal Open. 3, oead100, 2023.
  19. Iwaya T, Amaki M, Kanzaki H, Izumi C. A case report of repeat clipping for recurrent severe mitral regurgitation from both sides of the clip: those who run after two hares may catch both. European Heart Journal - Case Reports. 7, ytad372, 2023.
  20. Saji M, Yamamoto M, Kubo S, Asami M, Enta Y, Shirai S, Izumo M, Mizuno S, Watanabe Y, Amaki M, Kodama K, Yamaguchi J, Nakajima Y, Naganuma T, Bota H, Ohno Y, Yamawaki M, Ueno H, Mizutani K, Adachi Y, Otsuka T, Hayashida K; OCEAN-Mitral Investigators. Short-Term Outcomes Following Transcatheter Edge-to-Edge Repair: Insights From the OCEAN-Mitral Registry. JACC: Asia. 3, 766-773, 2023.
  21. Oka S, Watanabe Y, Amano M, Kamakura T, Izumi C, Kusano K. Feasibility of Catheter Ablation for Biatrial Tachycardia Using Multiple Catheters via an Atrial Shunt Device. Circulation Reports. 5, 367-368, 2023.
  22. Matsuda S, Kato T, Morimoto T, Taniguchi T, Minamino-Muta E, Matsuda M, Shiomi H, Ando K, Shirai S, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Jinnai T, Kato Y, Inuzuka Y, Morikami Y, Saito N, Minatoya K, Kimura T. Atrial fibrillation in patients with severe aortic stenosis. Journal of Cardiology. 81, 144-153, 2023.
  23. Iwaya T, Okada A, Tateishi E, Ohta Y, Morita Y, Ohta-Ogo K, Izumi C. Multimodality assessments of wild-type transthyretin cardiac amyloidosis with no ventricular hypertrophy. ESC Heart Failure. 10, 1412-1417, 2023.
  24. Izumi C, Matsuyama R, Yamabe K, Iwasaki K, Takeshima T, Murphy SME, Teng L, Igarashi A. In-Hospital Outcomes of Heart Failure Patients with Valvular Heart Disease: Insights from Real-World Claims Data. ClinicoEconomics and Outcomes Research. 15, 349-360, 2023.
  25. Nishikawa T, Shiba M, Ikeda Y, Ohta-Ogo K, Kondo T, Tabata T, Oka T, Shioyama W, Yamamoto H, Yasui T, Higuchi Y, Ishibashi-Ueda H, Honma K, Izumi C, Higo S, Hatakeyama K, Sakata Y, Fujita M. Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathy. European Heart Journal Open. 3, oead104, 2023.
  26. Hioki H, Watanabe Y, Kataoka A, Kozuma K, Shirai S, Naganuma T, Yamawaki M, Enta Y, Mizuno S, Ueno H, Ohno Y, Nakajima Y, Izumo M, Bouta H, Kodama K, Yamaguchi J, Kubo S, Amaki M, Asami M, Saji M, Mizutani K, Okazaki S, Hachinohe D, Otsuka T, Adachi Y, Yamamoto M, Hayashida K; OCEAN-Mitral Investigators. Impact of Gender on Mortality After Transcatheter Edge-to-Edge Repair for Functional Mitral Regurgitation. American Journal of Cardiology. 205, 12-19, 2023.
  27. Kubo S, Yamamoto M, Saji M, Asami M, Enta Y, Nakashima M, Shirai S, Izumo M, Mizuno S, Watanabe Y, Amaki M, Kodama K, Yamaguchi J, Nakajima Y, Naganuma T, Bota H, Ohno Y, Yamawaki M, Ueno H, Mizutani K, Adachi Y, Otsuka T, Hayashida K; OCEAN‐Mitral Investigators. One-Year Outcomes and Their Relationship to Residual Mitral Regurgitation After Transcatheter Edge-to-Edge Repair With MitraClip Device: Insights From the OCEAN-Mitral Registry. Journal of the American Heart Association. 12, e030747, 2023.
  28. Yoshihara F, Imazu M, Sakuma I, Hiroi Y, Hara H, Okazaki O, Ishiguro C, Izumi C, Noguchi T, Shiraiwa T, Nishioka N, Fujii K, Iwakura K, Tomonaga O, Kobayashi K, Takihata M, Yumoto K, Takase H, Himi T, Shimizu I, Murakami T, Wagatsuma K, Sato K, Hiramatsu T, Akabame S, Hata S, Asakura M, Kawabata T, Omae K, Ito S, Kitakaze M; DAPPER Investigators. DAPagliflozin for the attenuation of albuminuria in Patients with hEaRt failure and type 2 diabetes (DAPPER study): a multicentre, randomised, open-label, parallel-group, standard treatment-controlled trial. eClinicalMedicine. 66, 102334, 2023.
  29. Amano M, Izumi C, Watanabe H, Ozasa N, Morimoto T, Bingyuan B, Suwa S, Miyake M, Tamura T, Nakagawa Y, Kadota K, Inuzuka Y, Minamimoto Y, Furukawa Y, Kaji S, Suzuki T, Akao M, Inada T, Kimura T; CAPITAL-RCT Investigators. Effects of Long-Term Carvedilol Therapy in Patients With ST-Segment Elevation Myocardial Infarction and Mildly Reduced Left Ventricular Ejection Fraction. American Journal of Cardiology. 199, 50-58, 2023.
  30. Sato K, Seo Y, Ishizu T, Albakaa NK, Izumo M, Okada A, Izumi C, Inami S, Takeda Y, Onishi T, Izumi Y, Kumagai A, Fukuda T, Takahashi N, Kitai T, Iwano H, Sugawara S, Akasaka K, Harada K, Masaoka Y, Kusunose K, Tanabe K, Sakamoto T, Takamura T, Ieda M. Cardiac Reversibility and Survival After Transcatheter Aortic Valve Implantation in Patients With Low-Gradient Aortic Stenosis. Journal of the American Heart Association. 12, e029717, 2023.
  31. Fukue N, Ishida M, Taniyama M, Mukai-Yatagai N, Sakamoto T, Tamada T, Suetomi T, Tanabe K, Nakano Y. Factors Influencing Acceptance of the Chairperson Position at Annual Scientific Meetings of the Japanese Circulation Society - A Questionnaire Survey in Chugoku District. Circulation Reports. 5, 260-264, 2023.
  32. Okada A, Tateishi E, Morita Y, Ohta-Ogo K, Izumi C. Serial 99mTechnetium Pyrophosphate Scintigraphy and Multimodality Assessments After Different Doses of Tafamidis for Variant Transthyretin Cardiac Amyloidosis. Circulation: Heart Failure. 16, e009595, 2023.
  33. 根本 佳子, 北井 豪. 心筋症を心エコーで診る. Heart View. 27, 201-209, 2023.
  34. 山田 桂嗣, 北井 豪. 外科的大動脈弁生体弁置換術後. 心エコー. 24, 572-578, 2023.
  35. 天野 雅史. どのような基礎心疾患に注目して検査すべきか. 心エコー. 24, 283-291, 2023.
  36. 天野 雅史. 三尖弁閉鎖不全症における右室機能を考える. Heart View. 27, 1046-1051, 2023.
  37. 天野 雅史, 泉 知里. 肥大型心筋症に負荷をかけたら何がわかる? 注意点は? 心エコー. 24, 806-813, 2023.
  38. 北井 豪, 中川 頌子, 三浦 弘之, 青木 竜男. 心臓リハビリテーションってなに? HEART nursing. 36, 537-54, 2023.
  39. 山田桂嗣, 北井 豪. ICD一次予防の適応はガイドラインに従ってLVEFで判断してよいか? 心不全診療Controversy. 2023.
  40. 西崎 公貴, 北井 豪. 心不全に合併する電解質異常の治療. 心不全治療薬の考え方, 使い方 改訂2版. 267-273, 2023.
  41. 泉 知里. 心臓財団 季報. 250, 2023.
  42. 泉 知里. 心エコーを最強ツールにするために. 心エコー. 24, 621, 2023.
  43. 泉 知里. 三尖弁治療スタートガイド　カテーテルインターベンション時代の道しるべ. 2023.
  44. 泉 知里. 心エコー図検査に役立つ ヒト心臓形態のすべて. 2023.
  45. 森内 健史, 泉 知里. 心臓サルコイドーシスの活動性評価と治療. 日本臨床. 81, 1690-1697, 2023.
  46. 天木 誠. 人生を大きく変える小さなデバイス-カテーテル治療で進歩している弁膜症治療‐. Medical Practice. 40, 1928, 2023.
  47. 入江 勇旗, 泉 知里. MitraClip VS 最適薬物療法. 臨床と研究. 100, 1139-1144, 2023.
  48. 坂本 考弘. 心不全. 心エコー. 24, 486-495, 2023.
  49. 坂本 考弘. 肝うっ血を評価する. 心エコー. 24, 1216-1223, 2023.
  50. 坂本 考弘. 心膜液貯留. 若手心エコーフェローが教える心エコーのみかた. 2023.
  51. 庵地 雄太. 高齢心不全患者の思考, 行動, 感情を理解する - 老年心理学の視点から -. 心臓リハビリテーション. 29, 275-278, 2023.
  52. 北井 豪. 三尖弁カテーテル治療にTEEを活かす. Cardiovascular Anesthesia. 27, 149-149, 2023.
  53. 北井 豪. Cardiac sarcoidosis treated with nonsteroidal immunosuppressive therapy. The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders. 43, 80, 2023.
  54. 吉井 智洋, 泉 知里. 感染性心内膜炎の心エコー図検査. 診断と治療. 111, 1367-1373, 2023.
  55. 吉井 智洋, 泉 知里. 虚血性心疾患の慢性期に合併する弁膜症. 日本臨床 増刊号8 臨床冠動脈疾患学. 81, 457-462, 2023.
  56. 天木 誠. SHDカテーテルデバイス治療の時代に考える心不全患者へのアプローチ. Cardiovascular Anesthesia. 27, 92, 2023.
  57. 天野 雅史. iTEchoを臨床に活かす! 当院での使用経験より. 映像情報Medical. 55, 23-28, 2023.
  58. 柳 澤洋, 中川 靖章, 金森 敬彦, 森内 健史, 稲住 英明, 木下 秀之, 錦見 俊雄, 桑原 宏一郎, 中尾 一和. 肺動脈性肺高血圧症の病態形成におけるCNP-GC-B系の意義. 日本内分泌学会雑誌. 99, 289-289, 2023.
  59. 天野 雅史. 心不全診療における運動負荷心エコーの適応と課題. 循環器内科. 93, 509-516, 2023.
  60. 天野 雅史. 感染性心内膜炎. 内科. 131, 278-281, 2023.
  61. 天野 雅史. 二次性(機能性)TRは手術的修復より薬物治療を優先すべきか? 循環器ジャーナル. 71, 277-284, 2023.
  62. 岡田 厚. 心房性僧帽弁閉鎖不全症・三尖弁閉鎖不全症. 内科. 131, 264-267, 2023.
  63. 泉 知里. 弁膜症ガイドライン：いつ誰に治療介入すべきか. Heart view. 27, 1065-1069, 2023.